- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - '37182'
    - '37183'
  conditions:
    any_of:
    - dx_in_value_set: vs_variceal_bleeding_recurrent_2025_09
    - dx_in_value_set: vs_ascites_refractory_2025_09
    - dx_in_value_set: vs_hepatic_hydrothorax_2025_09
    all_of:
    - dx_in_value_set: vs_cirrhosis_2025_09
    - has_flag: child_pugh_class_a_or_b
    none_of:
    - dx_in_value_set: vs_hepatic_encephalopathy_grade_3_4_2025_09
    - has_flag: right_heart_failure
    - has_flag: portal_vein_thrombosis_complete
  logic:
    outcome: PA_REQUIRED
    notes: TIPS procedure for recurrent variceal bleeding or refractory ascites in
      Child-Pugh A/B cirrhosis - interventional radiology
  precedence: 95
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_hepatology_interventions_2025.pdf
    last_verified_at: '2025-09-11'
  id: rule_1f1e025f4514
- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - J3590
  conditions:
    any_of:
    - dx_in_value_set: vs_hepatic_encephalopathy_overt_2025_09
    - dx_in_value_set: vs_hepatic_encephalopathy_minimal_2025_09
    all_of:
    - dx_in_value_set: vs_cirrhosis_2025_09
    none_of:
    - has_flag: bowel_obstruction
    - has_flag: galactosemia
  logic:
    outcome: PA_REQUIRED
    notes: Lactulose therapy for overt or minimal hepatic encephalopathy in cirrhosis
      patients - first-line treatment
  precedence: 85
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_hepatology_interventions_2025.pdf
    last_verified_at: '2025-09-11'
  id: rule_514362c60223
- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - J3590
  conditions:
    all_of:
    - dx_in_value_set: vs_hepatic_encephalopathy_recurrent_2025_09
    - dx_in_value_set: vs_cirrhosis_2025_09
    - has_flag: lactulose_therapy_inadequate
    none_of:
    - has_flag: hypersensitivity_rifamycin
  logic:
    outcome: PA_REQUIRED
    notes: Rifaximin therapy for recurrent hepatic encephalopathy with inadequate
      lactulose response - second-line treatment
  precedence: 90
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_hepatology_interventions_2025.pdf
    last_verified_at: '2025-09-11'
  id: rule_0a9234abfd55
- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - '75774'
    - '75776'
  conditions:
    any_of:
    - dx_in_value_set: vs_hepatocellular_carcinoma_suspected_2025_09
    - dx_in_value_set: vs_liver_lesion_indeterminate_2025_09
    all_of:
    - dx_in_value_set: vs_cirrhosis_2025_09
    - has_flag: abnormal_surveillance_imaging
    none_of:
    - has_flag: contrast_allergy_severe
    - has_flag: renal_impairment_severe
  logic:
    outcome: PA_REQUIRED
    notes: CT angiography for HCC evaluation in cirrhosis patients with abnormal surveillance
      imaging - diagnostic workup
  precedence: 85
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_hepatology_interventions_2025.pdf
    last_verified_at: '2025-09-11'
  id: rule_81bfc3848ce0
- type: EDIT
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - '37182'
  conditions:
    all_of:
    - dx_in_value_set: vs_cirrhosis_2025_09
    - has_flag: child_pugh_class_c
    none_of:
    - has_flag: transplant_candidate_active
  logic:
    outcome: DENY
    notes: TIPS procedure contraindicated in Child-Pugh Class C cirrhosis unless active
      transplant candidate - safety restriction
  precedence: 98
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_hepatology_interventions_2025.pdf
    last_verified_at: '2025-09-11'
  id: rule_f73640b8155f
